Drug Discovery
Emerging trends in targeting "undruggable" RAS proteins for cancer treatment
It is estimated that one in five human cancers involve RAS mutations. Although once considered undruggable, this blog looks at recent advances in RAS inhibitors and emerging therapies.
Read the CAS Insights article